Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $78.57 million. The enterprise value is $35.83 million.
| Market Cap | 78.57M |
| Enterprise Value | 35.83M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 18.80 million shares outstanding. The number of shares has increased by 129.26% in one year.
| Current Share Class | 18.80M |
| Shares Outstanding | 18.80M |
| Shares Change (YoY) | +129.26% |
| Shares Change (QoQ) | +1.34% |
| Owned by Insiders (%) | 2.68% |
| Owned by Institutions (%) | 55.30% |
| Float | 14.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.67 |
| Forward PS | 0.60 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.19, with a Debt / Equity ratio of 1.08.
| Current Ratio | 5.19 |
| Quick Ratio | 4.02 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.81 |
Financial Efficiency
Return on equity (ROE) is -59.17% and return on invested capital (ROIC) is -18.18%.
| Return on Equity (ROE) | -59.17% |
| Return on Assets (ROA) | -15.54% |
| Return on Invested Capital (ROIC) | -18.18% |
| Return on Capital Employed (ROCE) | -33.27% |
| Weighted Average Cost of Capital (WACC) | 12.29% |
| Revenue Per Employee | $380,010 |
| Profits Per Employee | -$239,648 |
| Employee Count | 310 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.38 |
Taxes
In the past 12 months, Outset Medical has paid $936,000 in taxes.
| Income Tax | 936,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.55% in the last 52 weeks. The beta is 1.92, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.92 |
| 52-Week Price Change | -68.55% |
| 50-Day Moving Average | 4.56 |
| 200-Day Moving Average | 4.63 |
| Relative Strength Index (RSI) | 41.86 |
| Average Volume (20 Days) | 137,474 |
Short Selling Information
The latest short interest is 1.14 million, so 6.08% of the outstanding shares have been sold short.
| Short Interest | 1.14M |
| Short Previous Month | 1.22M |
| Short % of Shares Out | 6.08% |
| Short % of Float | 7.73% |
| Short Ratio (days to cover) | 7.42 |
Income Statement
In the last 12 months, Outset Medical had revenue of $117.80 million and -$74.29 million in losses. Loss per share was -$4.07.
| Revenue | 117.80M |
| Gross Profit | 49.20M |
| Operating Income | -66.05M |
| Pretax Income | -73.36M |
| Net Income | -74.29M |
| EBITDA | -62.73M |
| EBIT | -66.05M |
| Loss Per Share | -$4.07 |
Balance Sheet
The company has $147.19 million in cash and $104.45 million in debt, with a net cash position of $42.75 million or $2.27 per share.
| Cash & Cash Equivalents | 147.19M |
| Total Debt | 104.45M |
| Net Cash | 42.75M |
| Net Cash Per Share | $2.27 |
| Equity (Book Value) | 96.34M |
| Book Value Per Share | 5.13 |
| Working Capital | 183.96M |
Cash Flow
In the last 12 months, operating cash flow was -$38.32 million and capital expenditures -$559,000, giving a free cash flow of -$38.88 million.
| Operating Cash Flow | -38.32M |
| Capital Expenditures | -559,000 |
| Depreciation & Amortization | 3.31M |
| Net Borrowing | -93,000 |
| Free Cash Flow | -38.88M |
| FCF Per Share | -$2.07 |
Margins
Gross margin is 41.76%, with operating and profit margins of -56.06% and -63.06%.
| Gross Margin | 41.76% |
| Operating Margin | -56.06% |
| Pretax Margin | -62.27% |
| Profit Margin | -63.06% |
| EBITDA Margin | -53.25% |
| EBIT Margin | -56.06% |
| FCF Margin | n/a |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -129.26% |
| Shareholder Yield | -129.26% |
| Earnings Yield | -94.55% |
| FCF Yield | -49.48% |
Analyst Forecast
The average price target for Outset Medical is $7.67, which is 83.49% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.67 |
| Price Target Difference | 83.49% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 8.51% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 20, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Mar 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Outset Medical has an Altman Z-Score of -5.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.87 |
| Piotroski F-Score | 3 |